Valvular & structural heart disease

Plasma metabolomics uncovers key metabolites and enhances prediction of aortic stenosis: insights from prospective cohort and Mendelian randomisation studies

HeartPublished Prospective and two-sample Mendelian randomisation (MR) analyses

Authors' conclusion

Our study identified 39 metabolites with causal associations with AS risk, particularly apolipoprotein B-containing lipoproteins. The derived 12-metabolite panel significantly improved AS risk prediction, demonstrating the potential of NMR-based metabolomics to enhance AS risk stratification and targeted prevention.

Study context

Population
Participants with plasma nuclear magnetic resonance (NMR)-based metabolomic profiling (168 metabolites), followed for incident aortic stenosisSample sizes printed only for the prediction-model sets · training set 146,252 · testing set 62,678 · external validation cohort 21,546
Exposure
Clinical risk factors-based Cox regression model with the 12 metabolites added vs clinical risk factors alone, for aortic stenosis (AS) risk prediction
Outcome
Incident AS
Follow-up
Median 13.7 years
Methodological detailsNMR-based metabolomics, LASSO regression, external validation cohort
  • NMR-based metabolomics
  • LASSO regression
  • External validation cohort

Main finding

As reported in the abstract

AS events

2562

Metabolites significantly associated with AS risk in observational analyses (after adjustment and multiple-testing correction)

77 of 168

Metabolites causally associated with AS risk in MR analyses, including apolipoprotein B, apolipoprotein B-containing lipoprotein particles and lipid constituents within lipoprotein subclasses

39

Observational data: associations, not effects.

Secondary outcomes

Incident AS-related interventions or deaths (secondary outcome) · median follow-up of 13.7 years

AS-related interventions or deaths
1039
All of the 39 metabolites were associated with incident AS-related interventions or deaths

AS risk prediction: clinical risk factors model with vs without 12 LASSO-selected metabolites

Metabolites identified by LASSO in the training set
12
C index, testing set
0.780 to 0.791
C index, external validation cohort
0.764 to 0.786
Net reclassification improvement (NRI) and integrated discrimination improvement (IDI) significantly improved

Original publication

Plasma metabolomics uncovers key metabolites and enhances prediction of aortic stenosis: insights from prospective cohort and Mendelian randomisation studies. Heart. Published 4 August 2025. doi:10.1136/heartjnl-2025-326161

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.